nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advocating for change—Integration of efforts across the drug discovery and development continuum
|
Heffernan, Timothy P. |
|
|
43 |
4 |
p. 593-596 |
artikel |
2 |
Bridging the gap: The future of cancer research and clinical oncology in Cancer Cell
|
Mao, Steve |
|
|
43 |
4 |
p. 575-576 |
artikel |
3 |
CAR-T therapy in solid tumors
|
Du, Bing |
|
|
43 |
4 |
p. 665-679 |
artikel |
4 |
Diet-microbiome interactions in cancer
|
Abdeen, Suhaib K. |
|
|
43 |
4 |
p. 680-707 |
artikel |
5 |
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
|
Li, Housaiyin |
|
|
43 |
4 |
p. 757-775.e8 |
artikel |
6 |
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
|
Mayr, Lisa |
|
|
43 |
4 |
p. 740-756.e8 |
artikel |
7 |
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma
|
Lam, W.K. Jacky |
|
|
43 |
4 |
p. 728-739.e5 |
artikel |
8 |
Global alliances in translational cancer research
|
Luo, Hui-Yan |
|
|
43 |
4 |
p. 581-586 |
artikel |
9 |
Leveraging real-world data to advance biomarker discovery and precision oncology
|
Luo, Jiaqian |
|
|
43 |
4 |
p. 606-610 |
artikel |
10 |
Many paths, one destination: Bridging the gap in cancer care
|
Sahai, Erik |
|
|
43 |
4 |
p. 577-580 |
artikel |
11 |
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
|
Wang, Stephen L. |
|
|
43 |
4 |
p. 641-664 |
artikel |
12 |
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
|
Pauken, Kristen E. |
|
|
43 |
4 |
p. 623-640 |
artikel |
13 |
New horizons at the interface of artificial intelligence and translational cancer research
|
Yates, Josephine |
|
|
43 |
4 |
p. 708-727 |
artikel |
14 |
Precision oncology and genetic ancestry: The science behind population-based cancer disparities
|
Davis, Melissa Boneta |
|
|
43 |
4 |
p. 619-622 |
artikel |
15 |
Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups
|
Ji, Shunrong |
|
|
43 |
4 |
p. 776-796.e14 |
artikel |
16 |
The discrete charm of oncolytic viruses: Toward the finish line
|
Lowenstein, Pedro R. |
|
|
43 |
4 |
p. 611-618 |
artikel |
17 |
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative
|
|
|
|
43 |
4 |
p. 587-592 |
artikel |
18 |
Turning the kaleidoscope: Innovations shaping the future of clinical trial design
|
Marret, Grégoire |
|
|
43 |
4 |
p. 597-605 |
artikel |